Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06526312 · ClinicalTrials.gov registry record · NA
Primary Care Evidence-based Approach for Improving Lifelong Health
A NA study of Clinical Trial, sponsored by Arizona State University.
- Recruiting
- Registry status
- NA
- Development phase
- 840
- Enrollment target
- 1
- Study location
NCT06526312: Recruiting NA study of Clinical Trial, sponsored by Arizona State University.
NCT06526312 is a NA study of Clinical Trial that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 840 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06526312, a NA study of Clinical Trial, is actively recruiting participants, sponsored by Arizona State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 840 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the implementation and effectiveness of the Family Check-Up 4 Health (FCU4Health) intervention in primary care settings for reducing cardiovascular disease risk in children. Through a hybrid type 3 cluster randomized factorial trial and innovative technology-based strategies integrated with Electronic Health Records, the study aims to enhance intervention fidelity and engagement. Results will inform scalable approaches to promote child and family health behaviors, improve parenting skills, and potentially reduce child BMI, contributing to significant public health impacts in addressing cardiovascular health disparities.
Primary Outcome
Co-primary outcome of Aim 1: Fidelity to the motivational interviewing (MI) skills that are central to Family Check-Up 4 Health effects using the Lyssn automated coding platform. The system has been shown to be competitive with human coding using the Motivational Interviewing Skill Code (MISC) and the Motivational Interviewing Treatment Integrity Code (MITI 4). The Lyssn fidelity rating system consists of three dimensions: acceptance, empathy, and spirit, scored on a 7-point Likert scale. (1=low
Conditions Studied
Interventions
- BEHAVIORAL SMS/Text (CAMPI)
- BEHAVIORAL Fidelity Monitoring (Lyssn and COACH)
- BEHAVIORAL Family Check-Up 4 Health (FCU4Health)
Study Locations (1)
Arizona
- Denova Integrated Healthcare - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2025-06-09 |
| Est. Completion | 2028-07 |
| Phase | NA |
What NCT06526312 shows while recruiting
NCT06526312 is an interventional study that assigns participants to a tested intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Clinical Trial appearing as the primary indexed condition, and to 3 interventions - of which SMS/Text (CAMPI) is the first listed.
NCT06526312 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06526312 about?
NCT06526312 is a clinical study titled "Primary Care Evidence-based Approach for Improving Lifelong Health". This study investigates the implementation and effectiveness of the Family Check-Up 4 Health (FCU4Health) intervention in primary care settings for reducing cardiovascular disease risk in children. Through a hybrid type 3 cluster randomized factorial trial and innovative technology-based strategies ...
What is the current status of trial NCT06526312?
This trial is currently recruiting. It is a NA study. The enrollment target is 840 participants. The study started on 2025-06-09. Estimated completion is 2028-07.
What conditions does trial NCT06526312 study?
This clinical trial studies the following conditions: Clinical Trial.
What interventions are being tested in trial NCT06526312?
The interventions under investigation include: SMS/Text (CAMPI) (BEHAVIORAL), Fidelity Monitoring (Lyssn and COACH) (BEHAVIORAL), Family Check-Up 4 Health (FCU4Health) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06526312?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06526312 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical Trial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06526312's enrollment target sits among peer trials
840 133rd of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI